Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(2;18)(q11;q21)

Clinics and Pathology

Disease Non Hodgkin lymphoma.
Phenotype / cell stem origin One case to date, a 65-year-old female patient with a follicular lymphoma stage II-a (Impera et al., 2008).
Evolution Complete remission was obtained.

Cytogenetics

Additional anomalies A complex karyotype was found, with +11, and other anomalies.

Genes involved and Proteins

Gene Name AFF3
Location 2q11.2
Protein AFF3 belongs to a family of putative transcription factors also comprising AFF1 (AF4, FEL, MLLT2) in 4q21, AFF2 (FMR2, FRAXE) in Xq28 and AFF4 (AF5Q31) in 5q31. AFF3 has been found a susceptibility gene in autoimmune diseases, namely rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis (Barton et al., 2009; Castelino and Barton, 2010; Hinks et al., 2010). AFF3 is deleted in Nievergelt syndrome, an autosomal dominant mesomelic dysplasia (Steichen-Gersdorf et al., 2008). AFF3 was also found expressed in 20% of mammary tumor cells but not in normal acini in a study (To et al., 2005).
Gene Name BCL2
Location 18q21.33
Protein Antiapoptotic protein.

Result of the chromosomal anomaly

Hybrid gene
Description Fusion of AFF3 exon 1 to BCL2 exon 2.
  
Fusion Protein
Oncogenesis Leads to the overexpression of BCL2.
  

External links

Other databaset(2;18)(q11;q21) Mitelman database (CGAP - NCBI)

To be noted

Additional cases are needed to delineate the epidemiology of this rare entity:
you are welcome to submit a paper to our new Case Report section.

Bibliography

LAF-4 is aberrantly expressed in human breast cancer.
To MD, Faseruk SA, Gokgoz N, Pinnaduwage D, Done SJ, Andrulis IL.
Int J Cancer. 2005 Jul 1;115(4):568-74.
PMID 15704140
 
A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma.
Impera L, Albano F, Lo Cunsolo C, Funes S, Iuzzolino P, Laveder F, Panagopoulos I, Rocchi M, Storlazzi CT.
Oncogene. 2008 Oct 16;27(47):6187-90. Epub 2008 Jul 14.
PMID 18622426
 
Triangular tibia with fibular aplasia associated with a microdeletion on 2q11.2 encompassing LAF4.
Steichen-Gersdorf E, Gassner I, Superti-Furga A, Ullmann R, Stricker S, Klopocki E, Mundlos S.
Clin Genet. 2008 Dec;74(6):560-5. Epub 2008 Jun 23.
PMID 18616733
 
Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes.
Barton A, Eyre S, Ke X, Hinks A, Bowes J, Flynn E, Martin P; YEAR Consortium; BIRAC Consortium, Wilson AG, Morgan AW, Emery P, Steer S, Hocking LJ, Reid DM, Harrison P, Wordsworth P, Thomson W, Worthington J.
Hum Mol Genet. 2009 Jul 1;18(13):2518-22. Epub 2009 Apr 9.
PMID 19359276
 
Genetic susceptibility factors for psoriatic arthritis.
Castelino M, Barton A.
Curr Opin Rheumatol. 2010 Mar;22(2):152-6.
PMID 20084005
 
Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis.
Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E, Packham J, Worthington J; Childhood Arthritis Prospective Study; UKRAG Consortium; BSPAR Study Group, Thomson W.
Genes Immun. 2010 Mar;11(2):194-8. Epub 2010 Jan 14.
PMID 20072139
 

Contributor(s)

Written04-2010Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France

Citation

This paper should be referenced as such :
Huret JL . t(2;18)(q11;q21). Atlas Genet Cytogenet Oncol Haematol. April 2010 .
URL : http://AtlasGeneticsOncology.org/Anomalies/t0218q11q21ID2158.html

This paper is referenced by INIST as such :
http://documents.irevues.inist.fr/bitstream/2042/44947/1/04-2010-t0218q11q21ID2158.pdf   [ Bibliographic record ]

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sat Mar 9 12:36:54 CET 2013

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.